Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL575684 | 0.71 | PGK1 (0.32) | PGK1PGK2 | |
| SCHEMBL575800 | 0.69 | PGK1 (0.35) | PGK1PGK2 | |
| SCHEMBL15546607 | 0.67 | PGK1 (0.33) | PGK1PGK2 | |
| SCHEMBL1542035 | 0.64 | PGK1 (0.61) | PGK1PGK2 | |
| SCHEMBL498508 | 0.64 | PGK1 (0.32) | PGK1PGK2 | |
| SCHEMBL1574239 | 0.64 | PGK1 (0.32) | PGK1PGK2 | |
| SCHEMBL575683 | 0.64 | PGK1 (0.32) | PGK1PGK2 | |
| SCHEMBL14661748 | 0.64 | PGK1 (0.32) | PGK1PGK2 | |
| SCHEMBL186903 | 0.64 | PGK1 (0.45) | PGK1PGK2 | |
| Hydrochloric Acid SCHEMBL18641130 | 0.62 | PGK1 (0.58) | PGK1PGK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106217-B2 | anion is bis(pentafluoroethyl)phosphinic imide [(C2F5)2P(O)]2N- ; solvents for electrochemical reactions; salt formation | MERCK PATENT GMBH (DE) | 2012-01-31 | — | — | US | claimed |
| EP-2736913-A1 | METHOD FOR PRODUCING BIS(PERFLUOROALKYL)PHOSPHINIC ACID ANHYDRIDES | Merck Patent GmbH (DE) | 2014-06-04 | — | — | EP | disclosed |
| WO-2013013766-A1 | METHOD FOR PRODUCING BIS(PERFLUOROALKYL)PHOSPHINIC ACID ANHYDRIDES | MERCK PATENT GMBH (DE) | 2013-01-31 | — | — | WO | disclosed |
| US-8106217-B2 | anion is bis(pentafluoroethyl)phosphinic imide [(C2F5)2P(O)]2N- ; solvents for electrochemical reactions; salt formation | MERCK PATENT GMBH (DE) | 2012-01-31 | — | — | US | disclosed |
| US-20080194831-A1 | Low-Viscosity Ionic Liquids | MERCK PATENT GMBH (DE) | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194831-A1 | Low-Viscosity Ionic Liquids | ICMT, LPO, CIT | PGK1 1899/4885PGK2 916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.